Ava

Also: Boston Medical Center releases free app for clinicians treating OUD; ClearUP's OTC sinus relief device wins expanded indication.

A study published in JMIR found that a fertility wearable was able to use skin temperature, heart rate, and respiratory rate to help determine a woman's fertility window. 

Ava, a medical technology company focused on innovations in women's reproductive health, yesterday announced their expansion into Asia with the launch of an office in Hong Kong.

Here’s a look at how organizations are deploying artificial intelligence and machine learning for use cases ranging from doctor's assistants to social media and more.

Ava, the San Francisco- and Zurich-based maker of a connected menstrual cycle tracking bracelet, today announced the closure of a $30 million series B funding round.

Stephen Friend, a key driver of Apple’s recent healthcare efforts, appears to have quietly left the company in November 2017, according to a LinkedIn profile in which he refers to himself as “an independent entrepreneur.

San Francisco- and Zurich-based Ava, which makes a bracelet capable of tracking women’s menstrual cycles, has announced an update that will better allow their device to track when, or even if, the wearer has ovulated, according to a statement from the company.

Switzerland-based Ava, which is developing a fertility tracking system, raised $2.